Myda Advisors LLC Terns Pharmaceuticals, Inc. Call Options Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$6.49 - $10.8 $194,700 - $324,000	-30,000 Reduced 75.0%	10,000 $83,000
Q2 2024 Aug 13, 2024	BUY	$4.54 - $8.2 $44,946 - $81,180	9,900 Added 32.89%	40,000 $272,000
Q1 2024 May 14, 2024	BUY	$4.86 - $8.19 $49,086 - $82,719	10,100 Added 50.5%	30,100 $197,000
Q4 2023 Feb 13, 2024	BUY	$3.37 - $6.86 $67,400 - $137,200	20,000 New	20,000 $129,000

167

78.3M

580K

454K

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $214M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.